Aegon/€AGN

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Aegon

Aegon is a life insurance and long-term savings business listed in the Netherlands. It listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, the United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. Over recent years, Aegon has been moving through an extensive transformation program where management has sought to divest noncore operations and improve the risk profile of the business. Financial assets are the parts of the group that are now being run off. Aegon is looking to cycle out of capital-consumptive and volatile-earnings products and recycle funds into capital-light and more predictable strategic businesses.

Ticker

€AGN
Sector

Primary listing

AEX

Employees

15,500

Aegon Metrics

BasicAdvanced
€10B
8.20
€0.79
0.94
€0.35
5.37%

What the Analysts think about Aegon

Analyst ratings (Buy, Hold, Sell) for Aegon stock.

Bulls say / Bears say

Aegon reported a net profit of €606 million for H1 2025, a turnaround from a €65 million loss in H1 2024, with operating result rising 19% to €845 million, reflecting strong operational improvement (Reuters).
The company doubled its share buyback program to €400 million and raised its interim dividend by 19% to €0.19 per share for 2H 2025, signaling management's confidence in cash generation and commitment to shareholder returns (Reuters).
Free cash flow grew 18% year-on-year to €442 million in H1 2025, strengthening Aegon's financial flexibility for debt reduction and strategic reinvestment (Reuters).
Operating capital generation before holding funding and operating expenses slipped 2% to €576 million in H1 2025, coming in just above analyst forecasts and signaling potential challenges from Aegon's run-off financial assets (Reuters).
Aegon's contractual service margin dropped to €7.8 billion, affected by a €912 million negative mark-to-market impact from unfavorable currency movements, highlighting the company's sensitivity to FX volatility (Reuters).
Higher-than-expected U.S. mortality in Q1 2025 weighed on operating capital generation, with Aegon's OCG missing consensus estimates and leading to a new €200 million buyback aimed at stabilizing capital levels (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2025.

Aegon Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Aegon Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €AGN

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Sept25
Aegon
DividendPayment
€0.19Per share
FAQs